Introduction to the metabolic syndrome problematics;Úvod do problematiky metabolického syndromu

Vnitrni Lekarstvi

Volumn 51, Issue 1, 2005, Pages 48-52

  Souček, Miroslav ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Cardiovascular diseases; Dyslipidemy; Hypertension; Insulinresistance; Metabolic syndrome; Obesity

Indexed keywords

ADRENERGIC SYSTEM; ATHEROSCLEROSIS; DYSLIPIDEMIA; FIBRINOLYSIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; REVIEW;

EID: 20344365596     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
2. Kereiakes DJ, Willerson JT. Metabolic syndrome epidemic. Circulation 2003; 108: 1552-1553.
3. Anand SS, Yi Q, Gerstein H et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003; 108: 420-425.
4. Pelikánová T. Metabolický syndrom. Vnitŕ lék 2003; 49(12): 900-906.
5. Svačina Š. Metabolický syndrom. Praha: Triton 2001.
6. Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
7. Despres JP. Abdominal obesity and risk of coronary Artery disease. Can J Cardiol 1992; 8: 561-562.
8. Despres JP. Abdominal obesity as an important component of insulin-resistance syndrome. Nutrition 1993; 9: 452-459.
9. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoproteid cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-219.
10. Vaverková H. Dyslipoproteinemie a diabetes mellitus. Vnitř Lék 2000; 46: 532-538.
11. Vega GL, Clark LT, Tang A et al. Hepatic lipase activity is lower in African American men than in white American men: effects of 5 flanking polymorphism in the hepatic lipase gene. J Lipid Res 1998; 39: 228-232.
12. Couture P, Otvos JD, Cupples LA et al. Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study. Atherosclerosis 2000; 148: 337-343.
13. Greiner DZ, Personius BE, Andrew TC. Effect of withdrawal of chronic estrogen therapy on brachial artery vasoreactivity in women with coronary artery disease. Am J Cardiol 1999; 83(2): 247-249.
14. Lobo RA, Carmina E. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 2000; 132: 989-993.
15. Wilson PW, D'Agostino RB, Sullivan L et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-1872.
16. Wilson PW, Kannel WB, Silbershatz H et al. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999; 159: 1104-1109.
17. Češka R. Metabolický syndrom, HDL-cholesterol, diabetická dyslipidemie a kardiovaskulární riziko. Souč Klin Pr 2002; 1: 5-14.
18. Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762.
19. Pasternak RC. The ALLHAT lipid lowering trial: less is less. JAMA 2002; 288: 3042-3044.
20. Wilson WF, Grundy SM. The metabolic syndrome. Practical guide to origins and treatment. Circulation 2003; 108: 1537-1540.
21. Cífková R. Prevence ischemické choroby srdeční v dospělém věku. Kapitoly z kardiologie 2002; 2(4): 122-139.
22. Svačina Š, Owen K, Bretšnajderová A. Syndrom inzulínové rezistence. Praha: Triton 2003.
23. Vaverková H, Picker I, Vlachová I et al. Reavenův metabolický syndrom X v rodinách osob po předč asné ischemické cévní mozkové příhodě. Vnitř Lék 1993; 39: 745-754.
24. Perušičová J. Trendy soudobé diabetologie. Praha: Galén 2001; 9. vol.